Cambridge Cognition shares tumble as revenues fall short of expectations
Neuroscience technology developer Cambridge Cognition has seen revenues fall short of expectations and losses widen as a result of a switch in accounting practices.
Cambridge Cognition Holdings
37.00p
16:55 27/12/24
FTSE AIM All-Share
715.19
17:00 27/12/24
Health Care Equipment & Services
10,692.12
16:35 27/12/24
For the 2018 trading year, Cambridge adopted IFRS15, the new financial standard on revenue recognition, which it said had caused a "short-term adverse impact" to its financial performance.
The AIM-listed group expects revenues to be roughly £6m - shy of both the £7m it would've reported if not for the change and the £6.7m recorded a year earlier.
Despite its "improved sales order intake", Cambridge anticipates to turn in a loss of £1.5m for the year, a 400% widening on the previous year, as a result of the lower revenue.
"With a gross margin of over 90% on revenues impacted by the change to IFRS15, most of the reduction in revenue passes through to the bottom line," said Cambridge.
Looking forward, the group said it had a number of "materially significant contracts" waiting to be signed in the first quarter of its 2019 trading year and an order book of approximately £5.6m, an increase of 40% year-on-year.
Cambridge will post its full-year results on 21 March 2019.
As of 0850 GMT, Cambridge shares had tumbled 31.54% to 68.80p.